Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation

Documenti analoghi

• Preclinical development of virus‐like particle (VLP)‐based immunotherapy against house dust mite allergy
  di: Piyachat Patniboon, et al.
  Pubblicazione: (2024)
• Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation
  di: Alissa Cait, et al.
  Pubblicazione: (2024)
• Reaction severity and peach threshold amount during oral challenge in nonspecific lipid transfer protein allergy
  di: Natalia Pérez‐Sánchez, et al.
  Pubblicazione: (2024)
• Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma
  di: Hitasha Rupani, et al.
  Pubblicazione: (2024)
• Prevention of allergic airway and gut inflammation in humanized mice by lactobacilli, bifidobacteria, and butyrate
  di: Rahul Khatri, et al.
  Pubblicazione: (2024)